10/17/2024 3:54 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024 3:21 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:24 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:27 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:30 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:33 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
|
10/04/2024 3:18 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
08/13/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024 3:51 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024 7:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:05 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024 10:25 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:20 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:48 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024 5:02 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024 9:18 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:41 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:33 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024 2:38 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024 10:01 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024 9:22 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
06/04/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 9:16 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 1:19 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 8:04 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 3:43 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 9:09 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 9:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024 9:31 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 3:45 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024 9:24 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024 9:29 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024 9:43 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 7:57 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 3:15 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024 9:38 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 10:03 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 9:32 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024 3:49 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 9:12 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 2:44 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024 9:54 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 10:57 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024 5:01 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
04/02/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024 12:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024 10:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024 10:37 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 10:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 5:47 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024 10:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:12 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 10:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |